Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
09/22/1998 | US5811104 Efficacious vaccine against feline infectious peritonitis virus; manipulation to generate an immune response. |
09/22/1998 | US5811094 Recovering from human bone marrow; free of blood cells |
09/22/1998 | US5811089 Improving the patient immune system by administering at least one dosage of human embryo cells |
09/22/1998 | CA2117584C Gels for encapsulation of biological materials |
09/19/1998 | CA2224128A1 Cdna clone hnfdy20 that encodes a novel human 7-transmembrane receptor |
09/17/1998 | WO1998040746A1 Prenatal diagnostic methods |
09/17/1998 | WO1998040745A1 Method of detecting antigen-specific t-cells |
09/17/1998 | WO1998040510A1 Dna-based transposon system for the introduction of nucleic acid into dna of a cell |
09/17/1998 | WO1998040509A1 Chimeric adenoviral coat protein and methods of using same |
09/17/1998 | WO1998040507A1 Expression of a modified foamy virus envelope protein |
09/17/1998 | WO1998040503A1 Nucleic acid molecules encoding starch phosphorylase from maize |
09/17/1998 | WO1998040497A2 An ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in said method |
09/17/1998 | WO1998040496A1 Dna polymerases having improved labeled nucleotide incorporation properties |
09/17/1998 | WO1998040493A1 Fiv vaccine |
09/17/1998 | WO1998040492A1 Compositions and methods for elimination of unwanted cells |
09/17/1998 | WO1998040490A1 Bacillus thuringiensis toxins |
09/17/1998 | WO1998040489A1 Antisense base sequences |
09/17/1998 | WO1998040488A1 Anti-alphabeta3 humanized monoclonal antibodies |
09/17/1998 | WO1998040486A2 Secreted proteins and polynucleotides encoding them |
09/17/1998 | WO1998040483A2 28 human secreted proteins |
09/17/1998 | WO1998040468A1 Methods of constructing a gene mutation library and compounds and compositions thereof |
09/17/1998 | WO1998040408A1 Antibodies for inhibiting blood coagulation and methods of use thereof |
09/17/1998 | WO1998040407A1 Synaptic activation protein compositions and method |
09/17/1998 | WO1998040404A2 Secreted proteins and polynucleotides encoding them |
09/17/1998 | WO1998040403A1 Psca: prostate stem cell antigen |
09/17/1998 | WO1998040401A2 Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics |
09/17/1998 | WO1998040097A2 Bovine respiratory and enteric coronavirus as a vaccine |
09/17/1998 | WO1998040027A1 Augmentation and repair of dermal, subcutaneous, and vocal cord tissue defects |
09/17/1998 | WO1998030683A3 Nuclear transfer with differentiated fetal and adult donor cells |
09/17/1998 | WO1998024905A3 Secreted proteins and polynucleotides encoding them |
09/17/1998 | DE19711266A1 Neue humane Leber-Zellinie New human liver cell line |
09/17/1998 | DE19710496A1 Verfahren zum Nachweis antigenspezifischer T-Zellen nach Anreicherung von mononukleären Zellpopulationen A method for detecting antigen-specific T cells after enrichment of mononuclear cell populations |
09/17/1998 | DE19709775A1 Nucleinsäuremoleküle codierend Stärkephosphorylase aus Mais Nucleic acid molecules encoding starch phosphorylase from maize |
09/17/1998 | DE19709186A1 Filtrationsverfahren zur Trennung von Viren Filtration methods for separating viruses |
09/17/1998 | DE19708774A1 Nucleinsäuremoleküle codierend Enzyme die Fructosylpolymeraseaktivität besitzen Nucleic acid molecules encoding enzymes have the Fructosylpolymeraseaktivität |
09/17/1998 | DE19708713A1 Verwendung von anti-CD44 Antikörpern enthaltenden Präparationen zur Behandlung bestimmter Tumore und zur Unterdrückung von Immunreaktionen Using anti-CD44 antibodies containing preparations for the treatment of certain tumors and for the suppression of immune responses |
09/17/1998 | CA2287591A1 Synaptic activation protein compositions and method |
09/17/1998 | CA2284518A1 Anti-alphabeta3 humanized monoclonal antibodies |
09/17/1998 | CA2283746A1 Antibodies for inhibiting blood coagulation and methods of use thereof |
09/17/1998 | CA2283678A1 28 human secreted proteins |
09/17/1998 | CA2283632A1 Nucleic acid molecules encoding starch phosphorylase from maize |
09/17/1998 | CA2283628A1 Chimeric adenoviral coat protein and methods of using same |
09/17/1998 | CA2283490A1 Fiv vaccine |
09/17/1998 | CA2283416A1 Prenatal diagnostic methods |
09/17/1998 | CA2283195A1 Secreted proteins and polynucleotides encoding them |
09/17/1998 | CA2283193A1 Secreted proteins and polynucleotides encoding them |
09/17/1998 | CA2282807A1 Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics |
09/17/1998 | CA2281980A1 Bacillus thuringiensis toxins |
09/17/1998 | CA2281758A1 Repair of autologous tissue defects |
09/17/1998 | CA2280997A1 Dna-based transposon system for the introduction of nucleic acid into dna of a cell |
09/17/1998 | CA2254785A1 Antisense base sequences |
09/17/1998 | CA2232751A1 Novel compounds |
09/16/1998 | EP0864652A1 Expression of a foamy virus envelope protein |
09/16/1998 | EP0864651A2 Promoter of the cdc25B gene, its preparation and use |
09/16/1998 | EP0864650A2 Stress resistant plant |
09/16/1998 | EP0864649A2 Method for obtaining recombinant surface antigen of hepatitis B virus (HEP B) of higher immunogenic capacity and use thereof in a vaccine preparation |
09/16/1998 | EP0864645A1 (-)-strand rna virus vector having autonomously replicating activity |
09/16/1998 | EP0864585A1 Interleukin-18-receptor proteins |
09/16/1998 | EP0863990A1 Use of anti-sense sequences to increase responsiveness to gene amplification |
09/16/1998 | EP0863987A2 Vectors and methods for gene transfer to cells |
09/16/1998 | EP0863983A2 Starch branching enzyme ii of potato |
09/16/1998 | EP0863913A1 A method to increase the density of antigen on antigen presenting cells |
09/16/1998 | EP0863776A1 A biologic material comprising an efficient culture of bone marrow stem cells partially or completely differentiated into connective tissue cells and a three-dimensional biocompatible and biodegradable matrix consisting of a hyaluronic acid derivative |
09/16/1998 | EP0724637B1 Corticotropin-releasing factor 2 receptors |
09/16/1998 | EP0554356B1 A monoclonal antibody |
09/16/1998 | EP0530265B1 Dna encoding human 5-ht 1d receptors and uses thereof |
09/16/1998 | CN1193352A Human chitinase, its recombinant production, its use for decomposing chitin, and its use in therapy or prophylaxis against infection diseases |
09/16/1998 | CN1193350A Antigen non-specific glycosylation inhibiting factor derivatives |
09/16/1998 | CN1193349A Vaccine for infectious agents, compositions for treating and preventing HIV infections |
09/16/1998 | CN1193345A Neural transplantation using pluripotent neuroepithelial cells |
09/16/1998 | CN1193344A Compositions and methods to prevent microbial contamination of plant tissue culture media |
09/16/1998 | CN1193047A C3 plants expressing photosynthetic enzyme of C4 plants |
09/15/1998 | US5808174 Maize resistant to aryloxyphenoxyalkanecarboxylic acid herbicides |
09/15/1998 | US5808034 Genetic engineering |
09/15/1998 | US5808029 Genetic engineering |
09/15/1998 | US5808025 Polypeptide |
09/15/1998 | US5808024 Nucleic acids encoding high molecular weight major outer membrane protein of moraxella |
09/15/1998 | US5808012 Protein-enriched thermoplastics |
09/15/1998 | US5808008 Method of producing human pluripotent hematopoietic colony stimulating factor |
09/15/1998 | US5808002 Stem cell factor receptor-(c-kit)-specific monoclonal antibody A3C6E2 |
09/15/1998 | US5807999 Analyzing |
09/15/1998 | US5807995 Diagnosis and treatment of cancer |
09/15/1998 | US5807991 Human interleukin-5 receptor |
09/15/1998 | US5807988 Isolation, characterization, and use of the human and subunit of the high affinity receptor for immunoglobulin E |
09/15/1998 | US5807826 Semaphorin gene family |
09/15/1998 | US5807824 C5A receptor antagonists having substantially no agonist activity |
09/15/1998 | US5807744 Incubation; separation of bone marrow and tumor cells |
09/15/1998 | US5807740 Regulators of UCP2 gene expression |
09/15/1998 | US5807731 Antitumor |
09/15/1998 | US5807712 Genetic engineered protein |
09/15/1998 | US5807709 Secreted proteins and polynucleotides encoding them |
09/15/1998 | US5807706 Genetic engineering |
09/15/1998 | US5807703 Secreted proteins and polynucleotides encoding them |
09/15/1998 | US5807698 Human cyclin E |
09/15/1998 | US5807691 Polypeptides having serotonin receptor activity (5HT5A), nucleic acids coding for these polypeptides and uses thereof |
09/15/1998 | US5807689 Bioanalysis |
09/15/1998 | US5807686 Pluripotential quiescent stem cell population |
09/15/1998 | US5807678 Identification of gene mutations associated with congenital lipoid adrenal hyperplasia |
09/15/1998 | US5807555 Skin treatments with Smelophyllum capense extracts |
09/15/1998 | US5807550 Antibodies specifically recognizing somatotropin binding proteins |